We narrowed to 7,804 results for: ttl

Showing: 1301 - 1320 of 7804 results

Results per page:

Sort results by:

pDONR223_NFIL3_WT_V5

Plasmid

#82985

Purpose

Gateway Donor vector containing NFIL3, used as an over expression control for gene expression analysis. Part of the Target Accelerator Plasmid Collection.

Depositor

Jesse Boehm, Matthew Meyerson, David Root

Publication

Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

Insert

NFIL3 (NFIL3 Human)

Use

Gateway Cloning

Promoter

None

Available since

April 24, 2017

Availability

Academic Institutions and Nonprofits only

Cited by

1 Article

Enlarge
pYPQ166-OsPE2

Plasmid

#141080

Purpose

Gateway entry clone for CRISPR-Cas9(H840A) prime editing

Depositor

Yiping Qi

Publication

Tang et al Mol Plant. 2020 Mar 25. pii: S1674-2052(

Insert

zCas9(H840A)-OsM-MLV-RT

Use

CRISPR; Gateway compatible zcas9(h840a)-osm-mlv-rt

Tags

3x FLAG, NLS and NLS

Expression

Plant

Available since

May 26, 2020

Availability

Academic Institutions and Nonprofits only

Cited by

1 Article

Enlarge
pDONR221-NPC1L1_STOP

Plasmid

#161469

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

NPC1L1 (NPC1L1 Human)

Expression

Mammalian

Available since

Sept. 15, 2021

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR221_SLC22A4

Plasmid

#131903

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC22A4 (SLC22A4 Human)

Expression

Mammalian

Available since

Oct. 11, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR221_SLC15A3

Plasmid

#131898

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC15A3 (SLC15A3 Human)

Expression

Mammalian

Available since

Oct. 11, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR223_MEF2C_WT

Plasmid

#81735

Purpose

Gateway Donor vector containing MEF2C , part of the Target Accelerator Plasmid Collection.

Depositor

Jesse Boehm, William Hahn, David Root

Publication

Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

Insert

MEF2C (MEF2C Human)

Use

Gateway Cloning

Mutation

WT

Promoter

None

Available since

April 24, 2017

Availability

Academic Institutions and Nonprofits only

Enlarge
pEntry_HCoV-229E-Spike

Plasmid

#168971

Purpose

Gateway-compatible Entry vector

Depositor

Pascal Falter-Braun

Publication

Weller et al G3 (Bethesda). 2023 Jul 5;13(7):jkad105.

Insert

HCoV-229E-Spike (S )

Use

Gateway Cloning

Available since

July 5, 2023

Availability

Academic Institutions and Nonprofits only

Enlarge
pDONR221_SLC39A4

Plasmid

#132069

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC39A4 (SLC39A4 Human)

Expression

Mammalian

Available since

Nov. 8, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR221_SLC7A8

Plasmid

#132233

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC7A8 (SLC7A8 Human)

Expression

Mammalian

Available since

Nov. 8, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR221_SLC46A1

Plasmid

#132191

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC46A1 (SLC46A1 Human)

Expression

Mammalian

Available since

Oct. 28, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR221_SLC25A11

Plasmid

#132026

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC25A11 (SLC25A11 Human)

Expression

Mammalian

Available since

Oct. 25, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR221_SLC25A28

Plasmid

#132016

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC25A28 (SLC25A28 Human)

Expression

Mammalian

Available since

Oct. 25, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR221_SLC5A3

Plasmid

#132158

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC5A3 (SLC5A3 Human)

Expression

Mammalian

Available since

Oct. 22, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR221_MFSD10

Plasmid

#131890

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

MFSD10 (MFSD10 Human)

Expression

Mammalian

Available since

Oct. 9, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR223_BCL2L1_WT

Plasmid

#82193

Purpose

Gateway Donor vector containing BCL2L1 , part of the Target Accelerator Plasmid Collection.

Depositor

Jesse Boehm, William Hahn, David Root

Publication

Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

Insert

BCL2L1 (BCL2L1 Human)

Use

Gateway Cloning

Mutation

WT

Promoter

None

Available since

April 24, 2017

Availability

Academic Institutions and Nonprofits only

Enlarge
pENTR-D-TOPO-PAmCherry1-MCS

Plasmid

#60608

Purpose

Cloning PAmCherry1

Depositor

Steven Chu, Xiaolin Nan

Publication

Nan et al Proc Natl Acad Sci U S A. 2013 Nov 12;11

Insert

PAmCherry1

Use

Cloning

Available since

Nov. 4, 2014

Availability

Academic Institutions and Nonprofits only

Cited by

1 Article

Enlarge
pEnt L1L3 EF1a-tTA-3

Plasmid

#24415

Depositor

Edward Hsiao

Publication

Hsiao et al Stem Cell Res Ther. 2011 Mar 4. 2(2):11.

Type

Empty backbone

Use

Gateway Cloning

Available since

June 4, 2010

Availability

Academic Institutions and Nonprofits only

Enlarge
SV40 Large T K1 mutant in pENTR1A (w414-1)

Plasmid

#22270

Depositor

Eric Campeau

Insert

SV40 Large T antigen TK1 mutant (E107K)

Use

Gateway Cloning

Mutation

E107K (K1 mutation)

Available since

Dec. 17, 2009

Availability

Academic Institutions and Nonprofits only

Enlarge
pDONR221_SLC22A6

Plasmid

#131965

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC22A6 (SLC22A6 Human)

Expression

Mammalian

Available since

Oct. 21, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR221_SLC1A3

Plasmid

#131889

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC1A3 (SLC1A3 Human)

Expression

Mammalian

Available since

Oct. 9, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge